Notably, NPD1 was shown to potently reduce inflammatory pain and neuropathic pain in mice46,47, and we also showed that ARU-priming of macrophages could promote pain resolution after post-infection, and ARU treatment itself could rapidly alleviate pain after bacterial infection through GPR37 (Fig. 8h, i). Here, GPR37 is linked to bacterial infectious disease.